Tinker Biology
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Tinker Biology - overview
Established
2017
Location
Hangzhou, Zhejiang, China
Primary Industry
Food
About
Established in 2017 and based in Hangzhou, China, Tinker Biology is a microfluidic chip CDMO service provider that focuses on the development and production of food safety on-site rapid detection instruments and reagents based on microfluidic chip technology. The company has a 1000 square meters microfluidic laboratory and a 2000 square meters GMP standard plant. Tinker Biology has also obtained more than 50 authorized patents and soft documents, and has been awarded as National High-tech Enterprise, Hangzhou Qinglan Enterprise and Zhejiang Science and Technology Small and Medium-sized Enterprise. Dr.
Jiaming Ye, the founder of the company, worked at CapitalBio Corp. The company provides microfluidic product design and development and manufacturing solutions for medical in vitro diagnostics, organ-on-a-chip, nano drug/material synthesis, food safety/environmental protection testing and other industries, based on a full chain of microfluidic technology platform. The services provided by the company include bioanalysis, immunoassays, molecular diagnostics, chemical synthesis, droplet manipulation and cellular analysis.
Current Investors
TTGG Ventures, Panlin Capital, Qikai Investment Management
Primary Industry
Food
Sub Industries
Canned/Frozen Fruit & Vegetables, Hardware
Website
www.tinkerbio.com
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.